Lucia Gabriele
Rome, 00161, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
NSD2 and miRNAs as Key Regulators of Melanoma Response to Romidepsin and Interferon-α2b Treatment.
Journal: Cancer medicine
Published: September 18, 2024
Machine Learning Reassessment of Serum Immune Factors Shows No Unique Immune Profiles Linked to Disease Outcomes in SARS-CoV-2-infected Patients at Hospital Admittance.
Journal: European journal of immunology
Published: July 24, 2024
The Sybil prophecy: Searching for predictors of response to bevacizumab in glioblastoma.
Journal: Neuro-oncology
Published: June 17, 2024
Targeting CXCR4 impaired T regulatory function through PTEN in renal cancer patients.
Journal: British journal of cancer
Published: September 20, 2023
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Journal: Immunology
Published: July 27, 2023
Reversing vemurafenib-resistance in primary melanoma cells by combined romidepsin and type I IFN treatment through blocking of tumorigenic signals and induction of immunogenic effects.
Journal: International journal of cancer
Published: December 22, 2022
Molecular Analysis in a Glioblastoma Cohort-Results of a Prospective Analysis.
Journal: Journal of personalized medicine
Published: March 15, 2022
Anti-IFN-α/-ω neutralizing antibodies from COVID-19 patients correlate with downregulation of IFN response and laboratory biomarkers of disease severity.
Journal: European journal of immunology
Published: January 20, 2022
Tumor-on-a-chip platforms to study cancer-immune system crosstalk in the era of immunotherapy.
Journal: Lab on a chip
Published: December 14, 2020
α-Adrenoceptor stimulation attenuates melanoma growth in mice.
Journal: British journal of pharmacology
Published: November 11, 2020
Last Updated: 09/26/2026